Association between cholesterol and response to escitalopram and nortriptyline in patients with major depression: Study combining clinical and register-based information
Background: Little is known whether cholesterol levels affect depression treatment outcomes. We aimed to study the association between baseline and changes in blood cholesterol levels with drug-specific antidepressant response and long-term prognosis in patients with major depressive disorder (MDD)....
Main Authors: | Christiane Gasse, Christian Otte, Stefan M. Gold, Betina Elfving, Ole Mors, Ole Köhler-Forsberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Biomarkers in Neuropsychiatry |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666144622000120 |
Similar Items
-
Antidepressants Trial in Parkinson's Disease (ADepT-PD): protocol for a randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline on depressive symptoms in Parkinson’s disease
by: A Schrag, et al.
Published: (2022-12-01) -
A Randomized Clinical Trial Comparing Two Treatment Strategies, Evaluating the Meaningfulness of HAM-D Rating Scale in Patients With Major Depressive Disorder
by: Junaid Asghar, et al.
Published: (2022-05-01) -
Combination of Citalopram and Nortriptyline in Treatment of Moderate to Severe Major Depression: A Double-blind, Placebo- controlled Trial
by: Mohammad Reza Mohammadi, et al.
Published: (2006-04-01) -
Combination of Citalopram and Nortriptyline in Treatment of Moderate to Severe Major Depression: A Double-blind, Placebo- controlled Trial
by: Mohammad Reza Mohammadi, et al.
Published: (2006-03-01) -
Comparing the efficacy of duloxetine and nortriptyline in alleviating the symptoms of functional dyspepsia – a randomized clinical trial
by: Seyed Shahab Banihashem, et al.
Published: (2024-01-01)